These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9883831)

  • 21. Preclinical and clinical gene therapy for haemophilia.
    Chuah MK; Collen D; Vandendriessche T
    Haemophilia; 2004 Oct; 10 Suppl 4():119-25. PubMed ID: 15479384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene therapy for hemophilia.
    Ponder KP
    Curr Opin Hematol; 2006 Sep; 13(5):301-7. PubMed ID: 16888433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
    Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
    Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
    High KA
    Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemophilia Gene Therapy: Caught Between a Cure and an Immune Response.
    Herzog RW
    Mol Ther; 2015 Sep; 23(9):1411-2. PubMed ID: 26321180
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
    J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene therapy: Genie in a vector.
    Gould J
    Nature; 2014 Nov; 515(7528):S160-1. PubMed ID: 25427205
    [No Abstract]   [Full Text] [Related]  

  • 28. Gene transfer as an approach to treating hemophilia.
    High KA
    Semin Thromb Hemost; 2003 Feb; 29(1):107-20. PubMed ID: 12640573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelets: a new target for gene therapy of haemophilia B.
    Brown MA
    Thromb Haemost; 2002 Mar; 87(3):362-3. PubMed ID: 11916064
    [No Abstract]   [Full Text] [Related]  

  • 30. Gene and cell therapy for hemophilia: recent advances.
    Mimuro J; Sakata Y
    Rinsho Ketsueki; 2011 Jun; 52(6):361-7. PubMed ID: 21737988
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic Targeting of the Albumin Locus to Treat Hemophilia.
    Davidoff AM; Nathwani AC
    N Engl J Med; 2016 Mar; 374(13):1288-90. PubMed ID: 27028920
    [No Abstract]   [Full Text] [Related]  

  • 32. Current therapeutic relevance of liver gene transfer.
    Heard JM
    Hepatology; 1994 Jul; 20(1 Pt 1):253-4. PubMed ID: 8020896
    [No Abstract]   [Full Text] [Related]  

  • 33. AAV-mediated gene therapy for hemophilia.
    Couto LB; Pierce GF
    Curr Opin Mol Ther; 2003 Oct; 5(5):517-23. PubMed ID: 14601521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New approaches to treating haemophilia.
    Habeck M
    Mol Med Today; 2000 Jun; 6(6):214-5. PubMed ID: 10840378
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant adeno-associated virus delivers human factor IX in mice.
    Stewart A
    Mol Med Today; 1997 Sep; 3(9):368. PubMed ID: 9302683
    [No Abstract]   [Full Text] [Related]  

  • 36. Mutant macaque factor IX T262A: a tool for hemophilia B gene therapy studies in macaques.
    Ishiwata A; Mimuro J; Mizukami H; Kashiwakura Y; Yasumoto A; Sakata A; Ohmori T; Madoiwa S; Ono F; Shima M; Yoshioka A; Ozawa K; Sakata Y
    Thromb Res; 2010 Jun; 125(6):533-7. PubMed ID: 20170943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation.
    Herzog RW; Mount JD; Arruda VR; High KA; Lothrop CD
    Mol Ther; 2001 Sep; 4(3):192-200. PubMed ID: 11545609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy. Viral vectors still pack surprises.
    Marshall E
    Science; 2001 Nov; 294(5547):1640. PubMed ID: 11721031
    [No Abstract]   [Full Text] [Related]  

  • 39. Gene therapy. Panel reviews risks of germ line changes.
    Marshall E
    Science; 2001 Dec; 294(5550):2268-9. PubMed ID: 11743173
    [No Abstract]   [Full Text] [Related]  

  • 40. Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX.
    Bigger BW; Siapati EK; Mistry A; Waddington SN; Nivsarkar MS; Jacobs L; Perrett R; Holder MV; Ridler C; Kemball-Cook G; Ali RR; Forbes SJ; Coutelle C; Wright N; Alison M; Thrasher AJ; Bonnet D; Themis M
    Gene Ther; 2006 Jan; 13(2):117-26. PubMed ID: 16163377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.